Register project for the Characterization and Treatment of moderate to severe atopic Hand and Foot eczema (ReaCT aH&FE)

Study identification

• EU PAS number:
  EUPAS1000000727
• Study ID:
  1000000727
• Official title and acronym:
  Register project for the Characterization and Treatment of moderate to severe atopic Hand and Foot eczema (ReaCT aH&FE)
• DARWIN EU® study:
  No
• Study countries:
  Germany
• Study description:
  Prospective, national, multicenter, academic, clinical registry for patients with moderate-to-severe atopic hand- and foot eczema (aH&FE) (non-interventional registry study)
• Study status:
  Ongoing

Research institutions and networks

Institutions

TU Dresden, Department of Medicine

Germany

Study timelines

Date when funding contract was signed

Actual:19/02/2025

Study start date

Actual:22/08/2025

Date of final study report

Planned:27/06/2029

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

Sanofi-Aventis Deutschland GmbH

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable